Mediterranean Journal of Hematology and Infectious Diseases

Mediterranean Journal of Hematology and Infectious Diseases

Header

Editor in Chief: Giuseppe Leone

The Journal publishes topical reviews and original articles concerning both clinical hematology and infectious diseases. A particular attention will be deserved to original articles focusing on relationship between blood and infectious diseases.

How to submit an article:
Before submitting your article please provide to register yourself as author:

1(1) (2009): PROGRESS IN DIAGNOSIS AND THERAPY OF THALASSEMIA AND HEMOGLOBINOPATHIES.
Guest Editor: M. Domenica Cappelini

1(2) (2009): EPSTEIN-BARR VIRUS AND HEMATOLOGICAL DISEASES.
Guest Editor: Luigi Maria Larocca

1(3) (2009): VIRAL HEPATITIS AND HEMATOLOGICAL DISEASES.
Guest Editors: Eligio Pizzigallo and Antonio Gasbarrini

2 (1) (2010): REVIEWS ON HEPATITIS VIRUS, EBV, ORIGINAL ARTICLES.
Guest Editors: Eligio Pizzigallo and Luigi Maria Larocca

2(2) (2010): NEW DRUGS AND HEMOPOIETIC STEM CELL TRANSPLANTATION IN ONCOHEMATOLOGICAL DISEASES OF THE ELDERLY.
Guest editors: Giuseppe Leone and Lodovico Balducci

2(3) (2010): INFECTIONS AND THROMBOTIC RISK.
Guest Editor: Giovanni de Gaetano Co-Editor: Chiara Cerletti

3(1) (2011):

Topics:

  • FUNGAL INFECTIONS. Guest Ed.: L. Pagano
  • THROMBOSIS IN THE MEDITERRANEAN AREA. Guest Ed.: V. De Stefano
  • ACUTE PROMYELOCYTIC LEUKEMIA IN THE MEDITERRANEAN AREA AND IN THE DEVELOPING COUNTRIES: Guest Eds: F. Lo-Coco and G. Avvisati
  • THERAPY-RELATED MYELOID NEOPLASMS: Guest Ed.: R. Larson
4(1) (2012):


Announcements

 

TOPICS THROUGHOUT 2012

 

MALARIA IN THE WORD : 2012 Update

GUEST EDITORS : F. Castelli and E. Pizzigallo

CHRONIC LYMPHOID LEUKEMIA: Epidemiology and Update on Immunological Dysfunctions and Infections

GUEST EDITORS : D. Efremov and L. Laurenti

AUTOLOGOUS HEMOPOIETIC STEM CELL TRANSPLANTATION IN LEUKEMIA AND LYMPHOMA: 2012 Update

GUEST EDITORS : G. Meloni and G. Visani

 

 
Posted: 2012-01-13 More...
 

AUTHORS GUIDELINES

 

MJHID publishes topical reviews and original articles related to the diagnosis, management and research of hematologic and infectious diseases . The content of the MJHID is determined by the Editors.

MJHID, the Publisher, and the Editors of its publications assume no responsibility for the statements expressed by the contributors (and/or authors) of the articles.

The manuscript which is submitted to the journal must not contain previously published material or material under consideration for publication elsewhere. Accepted manuscripts become the property of MJHID and may not be republished.

All manuscripts will undergo peer review. A final review and a subsequent decision relative to publication will then be made by a MJHID editor.

Responsibilities of the Authors

By submitting a manuscript for publication, each author acknowledges having made a substantial contribution in:

The conception and design of the study.

The analysis and interpretation of the results.

The writing of the paper.

and has approved the final submitted version of the paper.


Each author thus also acknowledges responsibility for the integrity of the manuscript, assures the originality of the manuscript, and guarantees that duplicate or redundant publications or submissions have not occurred. The Editors reserve the right to request the original data obtained in the investigation. Authors are responsible for all statements made in the text.

Manuscript Submission

These instructions are based in part on recommendations in the Uniform Requirements for Manuscripts Submitted to Biomedical Journal [Ann. Intern. Med. 1997; 126: 36-47]. Variations from guidelines in this publication reflect the individual style of MJHID.

The authors should submit the manuscript as a complete file.

Submit an electronic version of text (as a MS WORD document), unlabeled and labeled images (as JPEG files).

The manuscript should be typed in times new roman font, double-spaced throughout on one side of A4/Letter paper with at least a 2.5 cm/1 inch margin on all sides. Number all pages consecutively, beginning with the title page.

There are no restrictions to page counts or number of figures/videos , however in the interest of readers we suggest limiting to a 10-12 page maximum (5000-6000 words).

Prepare a cover letter and the author license form (has to be sent via post or fax) signed by all authors.

Organize the manuscript as follows: title page, abstract, introduction, material and methods, results, discussion including a conclusion, acknowledgments, references, figure legends, and tables.

Keep acronyms and abbreviations to a minimum. When an abbreviation is used, define it at first mention and follow with the abbreviation in parentheses.

Categories of Submission

Review Articles

The author(s) is absolutely free to design the paper. No particular format is required for these articles. However, they should have an informative, unstructured abstract of about 200 words; we suggest a limiting to 10-12 pages (5-6000 words +references) , Mini reviews ( <4000 words and <100 references will be also considered) . References, figures, and legends follow the guidelines described below under Original Articles. The review articles are generally solicited by the Editors, but the journal may also consider reviews submitted on authors' own initiative: pre-submission inquiries are welcome




Original Articles

Title Page. The following information should appear: title of article; authors name, and last name; affiliations, grant support, and presentation in part or whole at any meeting. Identify the corresponding author and provide full mailing address, phone and fax numbers, and e-mail address.

Abstract. The abstract is limited to 300 words, and should describe the essential aspects of the investigation. In the first sentence state the background; in the second sentence state your specific purpose or hypothesis; in the third, fourth and fifth sentences summarize methods, results and conclusion. No references should be cited.

Introduction. Include brief background information on what has been done in the past in this area and the importance of your investigation. End with a statement of the purpose or hypothesis of the study.

Material and Methods. This section may be divided into subsections if it facilitates reading the paper. The research design, subjects, material used, and statistical methods should be included. Do not mix results and discussion into this section. Do not include manufacturers names unless the specific product is important to the procedures performed, in which case the city and state or country of the manufacturer should also be given. Indicate that informed consent has been obtained from patients who participated in clinical investigations. In animal experimentation, acknowledge that ethical guidelines were followed. When appropriate, indicate that approval was obtained from the institutions review board.

Results. This section may be divided into subsections if it facilitates reading the paper. All results based on methods must be included. If tables and graphic material will ease the understanding of the results, include them. Cite figures to illustrate the findings of the study.

Discussion. Start with limited background information and then discuss the results of the investigation in light of what has been published in the past, the limitations of your study, and potential directions for future research. In appropriate place, cite figures and graphs. A final conclusion should summarize the major findings of the study and their clinical usefulness.

Acknowledgments. Acknowledgments should appear on a separate page.

References. Section must be single spaced and begin on a separate page. References are numbered consecutively in the order in which they appear in the text. All references must be cited in the text, where numbers are enclosed in [square brackets] on line with the text (not superscript). Papers submitted but not yet accepted for publication should also be cited in the text. Inclusive page numbers ( e.g., 491-492) must be provided for all references. Journal names should be abbreviated according to MeSH. All authors should be listed in references.

Style and punctuation of references

Journal article. [Reference number] Marcucci G, Radmacher MD, Maharry K, Mrózek K, Ruppert AS, Paschka P,Vukosavljevic T, Whitman SP, Baldus CD, Langer C, Liu CG, Carroll AJ, Powell BL,Garzon R, Croce CM, Kolitz JE, Caligiuri MA, Larson RA, Bloomfield CD. MicroRNA expression in cytogenetically normal acute myeloid leukemia.N Engl J Med. 2008 ;358 :1919-28

Book. [Reference number] Noback CR, Demarest RJ. The Human Nervous System. 2nd Ed., New York, McGraw-Hill. 1975; 199-201.

Edited book. [Reference number] Wyngaarden JB. Principles of human genetics. In: Wyngaarden JB, Smith LH, eds. Cecil Textbook of Medicine. 18th Ed., Philadelphia, W. B. Saunders Company. 1988; 146-152.

URL (Web Page). [Reference number] Pantanowitz L, Früh K, Marconi S, Moses AV, Dezube BJ.

Pathology of rituximab-induced Kaposi sarcoma flare. http://www.biomedcentral.com/1472-6890/8/7 (published 23 July 2008)

Format: Author, if available. Title of page as listed on the site. Address of page (date accessed).

Tables. Each table should be given on a separate page. Each table has a short, descriptive title. Tables are numbered in the order cited in the text. Abbreviations are defined as footnotes at the bottom of each table. Tables should not duplicate data given in the text or figures.

Figures and Legends. The complete sets of original figures must be submitted. Legends should be in the present tense (e.g., 'Illustration shows ...'). Subjects' names must not appear on the figures. Labels should contrast well with the background. Images should be uniform in size and magnification. Illustrations should be free of all identifying information relative to the subject and institution. Line drawings should be professional in quality. Written permission for use of all previously published illustrations must be included with submission, and the source should be referenced in the legends. Written permission from any person recognizable in a photo is required. Legends must be double spaced, and figures are numbered in the order cited in the text. Submit color prints only if color is essential in understanding the material presented. Label all pertinent findings.

Case Reports

While the journal encourages the submission of full-length original articles, it will consider the publication of concise case reports. These should be usually educational and medically important. In addition to a title page (formatted as described above), include a summary (150 word) describing the essence of the report, an introduction (two or three sentences of background information); a case report (written in the past tense) or a description of the technique, and a discussion highlighting the educational value of the case or the technique. References should be limited (no more than 12 preferred) to only those that give essential background material. References, figures, and legends follow the guidelines described above in 'Original Articles.'

Letters to the Editor

Letters to the Editor may be used in primis to comment articles appeared in MJHID or other important journals and to give an opinion or suggestions relative to topics recently treated in the MJHID. Letters should be no more than 3 pages and should be submitted with a brief title. A maximum of 8 references may be included. Letters are published at the discretion of the journal and are subject to editing. Case reports could be submitted as letter to editor only when referred to articles appeared in MJHID.

Books for Review

Publishers and authors who wish to have their titles considered for review should send review copies to .
Unsolicited book reviews are not considered

The submission file is in Microsoft Word, RTF, or WordPerfect document file format.

This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Transfer of Copyright and Permission to Reproduce Parts of Published Papers. Authors will grant copyright of their articles to the Institute of Hematology, Catholic University, Rome . No formal permission will be required to reproduce parts (tables or illustrations) of published papers, provided the source is quoted appropriately and reproduction has no commercial intent. Reproductions with commercial intent will require written permission and payment of royalties.

 
Posted: 2012-01-13 More...
 
More Announcements...

Vol 4, No 1 (2012)

Table of Contents

Editorials

THE TRAGEDY CAUSED BY FAKE ANTIMALARIAL DRUGS PDF HTML
Pierre Ambroise-Thomas e2012027

Review Articles

BIOLOGY OF HUMAN MALARIA PLASMODIA INCLUDING PLASMODIUM KNOWLESI PDF HTML
Spinello Antinori, Laura Galimberti, Laura Milazzo, Mario Corbellino e2012013
MIGRATION AND MALARIA IN EUROPE PDF HTML
Begoña Monge-Maillo, Rogelio López-Vélez e2012014
MALARIA AND HIV IN ADULTS: When The Parasite runs into The Virus PDF
Emanuele Focà, Silvia Odolini, Nigritella Brianese, Gianpiero Carosi e2012032
APPROACHING THE TARGET: THE PATH TOWARDS AN EFFECTIVE MALARIA VACCINE PDF HTML
Alberto L. García-Basteiro, Quique Bassat, Pedro L. Alonso e2012015
SHORT HISTORY OF MALARIA AND ITS ERADICATION IN ITALY PDF HTML
Giancarlo Majori e2012016
CLINICAL ASPECTS OF UNCOMPLICATED AND SEVERE MALARIA PDF HTML
Alessandro Bartoloni, Lorenzo Zammarchi e2012026
EPIDEMIOLOGY OF IMPORTED MALARIA IN THE MEDITERRANEAN REGION PDF
Silvia Odolini, Philippe Gautret, Philippe Parola e2012031
DIAGNOSIS OF MALARIA INFECTION WITH OR WITHOUT DISEASE PDF
Zeno Bisoffi, Federico Gobbi, Dora Buonfrate, Jef Van den Ende e2012036
THE RISK OF THERAPY-RELATED MYELODYSPLASIA/ACUTE MYELOID LEUKEMIA IN HODGKIN LYMPHOMA HAS SUBSTANTIALLY DECREASED IN THE ABVD ERA ABOLISHING MECHLORETHAMINE AND PROCARBAZINE AND LIMITING VOLUMES AND DOSES OF RADIOTHERAPY PDF
Ercole Brusamolino, Manuel Gotti, Valeria Fiaccadori e2012022

Original Articles

MODULATING EFFECT OF THE −158 GΓ (C→T) XMN-1 POLYMORPHISM IN INDIAN SICKLE CELL PATIENTS PDF HTML
Sanjay Pandey, Sweta Pandey, Rahasya Mani Mishra, Renu Saxena e2012001
CHARACTERISTICS OF PATIENTS HOSPITALIZED WITH 2009 H1N1 INFLUENZA IN A TERTIARY CARE HOSPITAL IN SOUTHERN SAUDI ARABIA PDF HTML
Adnan Agha, Abdul Qader Alrawi, Abdelhaleem Bella, Mohammed S. AlAyed e2012002
OUTCOME OF ANTIFUNGAL COMBINATION THERAPY FOR INVASIVE MOLD INFECTIONS IN HEMATOLOGICAL PATIENTS IS INDEPENDENT OF THE CHOSEN COMBINATION PDF HTML
Rafael Rojas, José R. Molina, Isidro Jarque, Miguel A. Sanz e2012011
EPIDEMIOLOGY, DIAGNOSIS AND TREATMENT OF ACUTE PROMYELOCYTIC LEUKEMIA IN CHILDREN: THE EXPERIENCE IN CHINA PDF HTML
Li Zhang, Xiaofan Zhu e2012012
SUCCESSFUL LONG TERM ERADICATION OF FACTOR VIII INHIBITOR IN PATIENTS WITH ACQUIRED HAEMOPHILIA A IN SAUDI ARABIA PDF HTML
Galila F Zaher, Soheir S Adam e2012021
A STUDY ON THE EXPRESSION OF BCR-ABL TRANSCRIPT IN MIXED PHENOTYPE ACUTE LEUKEMIA (MPAL) CASES USING THE REVERSE TRANSCRIPTASE POLYMERASE REACTION ASSAY (RT-PCR) AND ITS CORRELATION WITH HEMATOLOGICAL REMISSION STATUS POST INITIAL INDUCTION THERAPY PDF HTML
PRATEEK bhatia, JOGESHWAR BINOTA, Neelam Varma, DEEPAK BANSAL, amita trehan, RAM KUMAR MARWAHA, PANKAJ MALHOTRA, SUBHASH VARMA e2012024
DIAGNOSTIC VALUE OF SIMULTANEOUS MEASUREMENT OF PROCALCITONIN, INTERLEUKIN-6 AND HS CRP IN PREDICTION OF EARLY-ONSET NEONATAL SEPSIS PDF HTML
alireza abdollahi, saeed shoar, fatemeh nayyeri, mamak shariat e2012028
MENDELIAN SUSCEPTIBILITY TO MYCOBACTERIAL DISEASE IN EGYPTIAN CHILDREN PDF
Nermeen Galal, Jeannette Boutros, Aisha Marsafy, Xiao-Fei Kong, Jacqueline Feinberg, Jean-Laurent Casanova, Stéphanie Boisson-Dupuis, Jacinta Bustamante e2012033

Case Reports

Successful treatment with eltrombopag in avoiding splenectomy for patients with chronic refractory immune thrombocytopenia PDF HTML
Alhossain A. Khalafallah, Zafreen Rahman, Kath Ogden, Terry Hannan e2012003
Bacillus Cereus catheter related bloodstream infection in a patient in a patient with acute lymphblastic leukemia PDF HTML
Lütfiye Öksüz, N Gurler, M Muftuoglu, FD Sargin, SK Besisik e2012004
Primary Pancreatic Lymphoma in a Patient with Maturity Onset Diabetes of the Young type 3 PDF HTML
Valentina Bozzoli, Maria Chiara Tisi, Luigi Pianese, Stefano Tumini, Vittoria Rufini, Maria Lucia Calcagni, Dario Pitocco, Alberto Larghi, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili, Francesco D'Alò, Stefan Hohaus e2012005
Transfusion associated peak in Hb HPLC chromatogram – a case report PDF HTML
Sonal Jain, Jasmita Dass, Hara Prasad Pati e2012006
Tuberculosis after gastrectomy, plasmatic concentration of antitubercular drugs PDF HTML
Giuseppe Vittorio De Socio, Antonio D'Avolio, Alessio Sgrelli, Lorena Baietto, Lisa Malincarne, Giovanni Di Perri, Franco Baldelli e2012007
Epstein-Barr Virus (EBV)-associated Haemophagocytic Syndrome PDF HTML
Lorenza Torti, Luigi Maria Larocca, Giuseppina Massini, Luciana Teofili e2012008
Bilateral Pleural Effusions due to Pulmonary Amyloidosis as the Presenting Manifestation of Multiple Myeloma PDF HTML
Abhishek Agarwal, Sandeep Singla, Meghana Bansal, Bijay Nair e2012010
A case of atypical prolonged hematologic toxicity with azacitidine in Chronic Myelomonocytic Leukemia (CMML), review of literature and a proposal of management PDF HTML
Elena Elli, Caterina Cecchetti, Angelo Belotti, Lorenza Borin, Enrico Maria Pogliani e2012017
Adjuvant corticosteroid therapy in hepatosplenic candidiasis-related IRIS PDF HTML
Cengiz Bayram, Ali Fettah, Nese Yarali, Abdurrahman Kara, Fatih Mehmet Azik, Betül Tavil, Bahattin Tunc e2012018
Methotrexate induced lung injury in a patient with primary CNS lymphoma : A case report PDF HTML
puneet chhabra, arjun dutt law, dr vikas suri, dr pankaj malhotra, dr subhash varma e2012020
Hypophosphatemic osteomalacia associated with tenofovir: a multidisciplinary approach is required. PDF HTML
Giuseppe Vittorio De Socio, Gianluigi Fabbriciani, Marco Massarotti, Salvatore Messina, Enisia Cecchini, Bianca Marasini e2012025
Microangiopathic Hemolytic Anemia in 57-year-old woman with Borderline Serous Tumor of the Ovary:Real-Time Management of Common Pathways of Hemostatic Failure PDF
Gloria Joan Morris e2012030
BONE MARROW INVOLVEMENT IN A PATIENT WITH ALPHA HEAVY CHAIN DISEASE:RESPONSE TO TETRACYCLINE TREATMENT PDF
Zahit Bolaman, Irfan Yavasoglu, Gokhan Sargin, Gurhan Kadikoylu, Firuzan Kacar Doger e2012034
Bortezomib a safety treatment for patients with Multiple Myeloma and Cystic Fibrosis PDF
Fabiana Gentilini, Anna Levi, Vincenzo Federico, Eleonora Russo, Robin Foà, Maria Teresa Petrucci e2012035

Letters to Editor

Unusual hand radiographic presentation in a patient on hemodialysis PDF HTML
Chrysoula Pipili, Eirini Grapsa, Helen Tzanatos e2012009
Aplastic anaemia with microfilaria in marrow aspirate PDF HTML
Narender Tejwnai, Seema Tyagi, Jasmita Dass e2012019

MJHID Educational Material

Multiple bone and joint disease in a sickle cell anaemia patient: a case report PDF HTML
John Ayodele Olaniyi, Adekunle E Alagbe, Olutoogun O Toluwalase, Olorunsogo E Busari e2012023
Fascioliasis : a not rare cause of hypereosinophilia in developing countries, present in developed too PDF
GÜLALİ AKTAŞ, İsmail Necati Hakyemez, Abdülkadir Küçükbayrak, Safiye Gürel, Tekin Taş e2012029


Mediterr J Hematol Infect Dis ISSN 2035-3006

$